A revision of Billingham's tenets: the central role of lymphocyte migration in acute graft-versus-host disease.

The migration of cells from vascular to extravascular compartments effects a sequential cascade of events, involving an interplay between adhesion molecules and chemokines. All T cell-mediated immune responses, of which acute graft-versus-host disease (GVHD) is an example, require that effector cells reach their target tissues. Lymphocytes do not enter specific tissues because they "see" a given antigen; they enter because they possess the requisite combination of homing receptors and chemokine receptors to engage the endothelium at the target tissue(s). Billingham's tenets on the immunobiology of GVHD must be expanded to accommodate this obligatory homing component. Because GVHD is relatively organ specific--principally affecting the skin, gut, and liver-our increasing knowledge of the pertinent adhesion molecules and chemokines directing effector cell trafficking to these sites offers novel therapeutic approaches for prevention or treatment of GVHD. The potential efficiency of this form of therapy could eliminate the use of graft manipulations (eg, T-cell depletion) and broad immunosuppressives, thereby lessening infectious complications and preserving the potent graft-versus-malignancy effect of allogeneic hematopoietic stem cell transplantation.

• Publication year

  2006

• Venue

  Biology of Blood and Marrow Transplantation

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.BBMT.2005.09.015PMID 16399577
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rules of recruitment for Th1 and Th2 lymphocytes in inflamed liver: a role for alpha-4 integrin and vascular adhesion protein-1.

  2005cited by this paper
• The lymphocyte homing receptors: gatekeepers of the multistep paradigm

  2005cited by this paper
• The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules.

  2005cited by this paper
• Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD.

  2005cited by this paper
• Retinoic acid imprints gut-homing specificity on T cells.

  2004cited by this paper
• Differential Roles for CCR5 Expression on Donor T Cells during Graft-versus-Host Disease Based on Pretransplant Conditioning1

  2004cited by this paper
• FTY720: Sphingosine 1‐Phosphate Receptor‐1 in the Control of Lymphocyte Egress and Endothelial Barrier Function

  2004cited by this paper
• LPAM (alpha 4 beta 7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease.

  2004cited by this paper
• LPAM (α4β7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease

  2004cited by this paper
• L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection.

  2004cited by this paper
• Immune surveillance in the skin: mechanisms and clinical consequences

  2004cited by this paper
• CD44-hyaluronic acid interactions mediate shear-resistant binding of lymphocytes to dermal endothelium in acute cutaneous GVHD.

  2004cited by this paper
• E-Selectin, Thymus- and Activation-Regulated Chemokine/CCL17, and Intercellular Adhesion Molecule-1 Are Constitutively Coexpressed in Dermal Microvessels: A Foundation for a Cutaneous Immunosurveillance System1

  2004cited by this paper
• Chemokines in the systemic organization of immunity

  2003influential reference
• Prevention of leukocyte migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-associated antigen.

  2003cited by this paper
• Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins1

  2003cited by this paper
• Faith supported by reason: mechanistic support for the use of polyclonal antibodies in transplantation.

  2003cited by this paper
• Inhibition of monocyte/endothelial cell interactions and monocyte adhesion molecule expression by the immunosuppressant mycophenolate mofetil

  2003cited by this paper
• Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720.

  2003cited by this paper
• Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction

  2003cited by this paper
• Glycosylation-dependent inhibition of cutaneous lymphocyte-associated antigen expression: implications in modulating lymphocyte migration to skin.

  2003cited by this paper
• Direct Real-Time Observation of E- and P-Selectin-Mediated Rolling on Cutaneous Lymphocyte-Associated Antigen Immobilized on Western Blots1

  2002cited by this paper
• Blocking L‐selectin and α4‐integrin changes donor cell homing pattern and ameliorates murine acute graft versus host disease

  2001cited by this paper
• Death with functioning graft--a preventable cause of graft loss.

  2001cited by this paper
• In vivo microscopic assessment of microcirculatory changes in a concordant xenogeneic primate experimental set up.

  2001cited by this paper
• Suppression of hepatic lesions in a murine graft-versus-host reaction by antibodies against adhesion molecules.

  2000cited by this paper
• Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease.

  1999cited by this paper
• Mycophenolate mofetil impairs transendothelial migration of allogeneic CD4 and CD8 T-cells.

  1999cited by this paper
• Molecular Mechanisms of Lymphocyte Homing to Peripheral Lymph Nodes

  1998cited by this paper
• Cyclosporin A decreases lymphocyte migration to the heart allograft through suppression of their L-selectin expression.

  1998cited by this paper
• Leucocyte adhesion under flow conditions: principles important in tissue engineering.

  1996cited by this paper
• FK506 inhibits human lymphocyte migration and the production of lymphocyte chemotactic factors in liver allograft recipients

  1996cited by this paper
• Lymphocyte Migration Following Bone Marrow Transplantation

  1995cited by this paper
• Adhesion molecules on intermediate TCR cells. I. Unique expression of adhesion molecules, CD44+ L-selectin-, on intermediate TCR cells in the liver and the modulation of their adhesion by hyaluronic acid.

  1995cited by this paper
• Involvement of alpha 1 and alpha 4 integrins in gut mucosal injury of graft-versus-host disease.

  1995cited by this paper
• The effects of corticosteroids on lymphocyte recirculation in humans: analysis of the mechanism of impaired lymphocyte migration to lymph node following methylprednisolone administration.

  1995cited by this paper
• Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm.

  1994cited by this paper
• Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1.

  1993cited by this paper
• Inhibition by rapamycin of leukocyte migration and bronchial hyperreactivity induced by injection of Sephadex beads to guinea‐pigs

  1993cited by this paper
• α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1

  1993cited by this paper
• L-selectin-mediated lymphocyte rolling on MAdCAM-1

  1993cited by this paper
• Physiologic migration of lymphocytes to lymph nodes following bone marrow transplantation: role in immune recovery.

  1993cited by this paper
• Vessel associated adhesion molecules in normal skin and acute graft-versus-host disease.

  1991cited by this paper
• Lymphocyte-Homing Receptors and Preferential Migration Pathways

  1991cited by this paper
• Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity.

  1991cited by this paper
• Requirements for the induction and adoptive transfer of cyclosporine- induced syngeneic graft-versus-host disease

  1989cited by this paper
• Effects of anti-inflammatory agents on lymphocyte migration stimulated by the interferons, tumor necrosis factor and cutaneous inflammation.

  1989cited by this paper
• The pathology of the graft-versus-host reaction (GVHR) in adults receiving bone marrow transplants.

  1976cited by this paper
• Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors.

  1974cited by this paper
• The biology of graft-versus-host reactions.

  1966cited by this paper
• The biology of graft-versus-host reactions.

  1966cited by this paper

• Not just a viral co-receptor: the role of CCR5 in HIV cure after allogeneic stem cell transplantation.

  2026cites this paper
• Combined Solid Organ Transplant and Transfusion-Associated Graft-Versus-Host Disease in a Lung Transplant Recipient: An Uncertain Culprit With Lethal Complications

  2024cites this paper
• Separation of GVL from GVHD -location, location, location

  2023cites this paper
• Enforced mesenchymal stem cell tissue colonization counteracts immunopathology

  2022cites this paper
• Retention of Donor T Cells in Lymphohematopoietic Tissue and Augmentation of Tissue PD-L1 Protection for Prevention of GVHD While Preserving GVL Activity

  2022cites this paper
• C–C chemokine receptor 5 and acute graft‐versus‐host disease

  2022cites this paper
• Different kinetics and risk factors for isolated extramedullary relapse after allogeneic hematopoietic stem cell transplantation in children with acute leukemia.

  2021cites this paper
• Acute Graft-versus-Host Disease: An Immunologic Perspective

  2021cites this paper
• Biomarkers for Early Complications of Endothelial Origin After Allogeneic Hematopoietic Stem Cell Transplantation: Do They Have a Potential Clinical Role?

  2021cites this paper
• Modulating endothelial cells with EGFL7 to diminish aGVHD after allogeneic bone marrow transplantation in mice

  2021cites this paper
• Donor‐derived M2 macrophages attenuate GVHD after allogeneic hematopoietic stem cell transplantation

  2021cites this paper
• γδ T Cells May Aggravate Acute Graft-Versus-Host Disease Through CXCR4 Signaling After Allogeneic Hematopoietic Transplantation

  2021cites this paper
• LYG1 Deficiency Attenuates the Severity of Acute Graft-Versus-Host Disease via Skewing Allogeneic T Cells Polarization Towards Treg Cells

  2021cites this paper
• 5-Aminolevulinic acid combined with sodium ferrous ameliorated liver injury in a murine acute graft-versus-host disease model by reducing inflammation responses through PGC-1α activation

  2021cites this paper
• Follicular regulatory T cell biology and its role in immune‐mediated diseases

  2021cites this paper
• 5-Aminolevulinic acid combined with sodium ferrous citrate (5-ALA/SFC) ameliorated liver injury in a murine acute graft-versus-host disease model by reducing inflammation responses through PGC1-α activation.

  2020cites this paper
• Current Preventions and Treatments of aGVHD: From Pharmacological Prophylaxis to Innovative Therapies

  2020cites this paper
• Immune checkpoints in hematologic malignancies: What made the immune cells and clinicians exhausted!

  2020influential citation
• Plasmacytoid dendritic cell biology and its role in immune‐mediated diseases

  2020cites this paper
• Defibrotide inhibits donor leucocyte‐endothelial interactions and protects against acute graft‐versus‐host disease

  2020cites this paper
• Mobilization of Leukemic Cells Using Plerixafor as Part of a Myeloablative Preparative Regimen for Patients with Acute Myelogenous Leukemia Undergoing Allografting: Assessment of Safety and Tolerability.

  2019cites this paper
• Targeting Leukemia Stem Cell-Niche Dynamics: A New Challenge in AML Treatment

  2019cites this paper
• In Vivo Imaging of GVHD and GVL

  2019cites this paper
• Graft-Versus-Host Disease

  2019cites this paper
• Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia: clinical characteristics, incidence, risk factors and outcomes

  2018cites this paper
• Alterations of CCR5 and CCR7 expression on donor peripheral blood T cell subsets after mobilization with rhG-CSF correlate with acute graft-versus-host disease.

  2017cites this paper
• Circulating endothelial cell count: a reliable marker of endothelial damage in patients undergoing hematopoietic stem cell transplantation

  2017cites this paper
• Acute Graft Versus Host Disease: A Comprehensive Review.

  2017cites this paper
• The effect of CCR5Δ32 on the risk of grade 3‐4 acute graft‐versus‐host disease after allogeneic hematopoietic stem cell transplantation: A systematic review and meta‐analysis

  2017cites this paper
• Three relapses after a haploidentical transplantation in a pediatric patient: Cure with no further transplantation

  2017cites this paper
• Donor lymphocyte infusions in AML and MDS: Enhancing the graft-versus-leukemia effect.

  2017cites this paper
• The PD-1 Axis Enforces an Anatomical Segregation of CTL Activity that Creates Tumor Niches after Allogeneic Hematopoietic Stem Cell Transplantation.

  2016influential citation
• Pathology of Hematopoietic Cell Transplantation

  2016cites this paper
• Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation.

  2016cites this paper
• This information is current as Cytokines in Graft-versus-Host Disease

  2015cites this paper
• Understanding graft-versus-host disease. Preliminary findings regarding the effects of exercise in affected patients.

  2015cites this paper
• Involvement of the CX3CL1 (fractalkine)/CX3CR1 pathway in the pathogenesis of acute graft‐versus‐host disease

  2015cites this paper
• CCR7 Expressing Mesenchymal Stem Cells Potently Inhibit Graft-versus-Host Disease by Spoiling the Fourth Supplemental Billingham’s Tenet

  2014cites this paper
• Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201.

  2014cites this paper
• Mesenchymal stem cells attenuate rat graft-versus-host disease.

  2014cites this paper
• Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: considerations for evidence-based GVHD prophylaxis

  2014cites this paper
• Depletion of host CCR7(+) dendritic cells prevented donor T cell tissue tropism in anti-CD3-conditioned recipients.

  2014cites this paper
• Clinical significance of anti-endothelial cell antibody in allogeneic hematopoietic stem cell transplantation recipients with graft-versus-host disease

  2014cites this paper
• Rôle des lymphocytes Th17 et des cellules dendritiques plasmocytoïdes dans la réaction aiguë du greffon contre l'hôte après allogreffe de cellules souches hématopoïétiques

  2014cites this paper
• Regulatory T cells in haematopoietic stem cell transplantation

  2014cites this paper
• Implication de l'axe CX3CL1/CX3CR1 dans la physiopathologie de la réaction aiguë du greffon contre l'hôte en allogreffe de cellules souches hématopoïétiques

  2014cites this paper
• New ways to separate Graft‐versus‐Host Disease and Graft‐versus‐Tumour effects after allogeneic haematopoietic stem cell transplantation

  2013cites this paper
• c‐Rel is an essential transcription factor for the development of acute graft‐versus‐host disease in mice

  2013cites this paper
• Recombinant CD95-Fc (APG101) prevents graft-versus-host disease in mice without disabling antitumor cytotoxicity and T-cell functions.

  2013cites this paper
• Biomarkers for acute GVHD: can we predict the unpredictable?

  2013cites this paper
• in minimal GVHD with retention of antitumor activity In vivo trafficking and survival of cytokine-induced killer cells resulting

  2013cites this paper
• Homing characteristics of donor T cells after experimental allogeneic bone marrow transplantation and posttransplantation therapy for multiple myeloma.

  2013cites this paper
• Cellular Therapy for Hematology Malignancies: Allogeneic Hematopoietic Stem Transplantation, Graft-Versus-Host Disease, and Graft Versus Leukemia Effects

  2012cites this paper
• Bone Marrow-Derived Conventional, But Not Cloned, Mesenchymal Stem Cells Suppress Lymphocyte Proliferation and Prevent Graft-Versus-Host Disease in Rats

  2012cites this paper
• Long-Term Complete Remission in an Acute Myeloid Leukemia Patient with Isolated Central Nervous System Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

  2012cites this paper
• Экстрамедуллярные рецидивы после трансплантации аллогенных гемопоэтических клеток и трансфузий лимфоцитов донора

  2012cites this paper
• Biological and Genetic Aspects of Donor-Recipient Matching in HSCT

  2012cites this paper
• Regulatory T Cells Inhibit CD8+ T-Cell Tissue Invasion in Human Skin Graft-Versus-Host Reactions

  2012cites this paper
• Th17 Mediated Alloreactivity Is Facilitated by the Pre-Transplant Microbial Burden of the Recipient

  2012cites this paper
• Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease.

  2012cites this paper
• Shift of Graft-Versus-Host-Disease Target Organ Tropism by Dietary Vitamin A

  2012cites this paper
• Bortezomib regulates the chemotactic characteristics of T cells through downregulation of CXCR3/CXCL9 expression and induction of apoptosis

  2012cites this paper
• [Allogeneic hematopoietic stem cell transplantations].

  2011cites this paper
• Study of the Incidence of Muco-cutaneous Graft Versus Host Disease among patients undergoing Allogeneic Hematopoietic Stem Cell Transplantation in an Indian setting

  2011cites this paper
• Allogreffes de cellules souches hématopoïétiques

  2011cites this paper
• Regulatory T cell expression of CLA or α4β7 and skin or gut acute GVHD outcomes

  2011cites this paper
• Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation: better prognosis than systemic relapse.

  2011cites this paper
• Evidence that erythrocyte DARC-positive phenotype can affect the GVHD occurrence after HLA-identical sibling HSCT.

  2011cites this paper
• Regulation of acute graft-versus-host disease by microRNA-155.

  2010cites this paper
• Decrease of CD4(+)CD25(+) regulatory T cells and TGF-beta at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation.

  2010cites this paper
• Separation of antileukemic effects from graft-versus-host disease in MHC-haploidentical murine bone marrow transplantation: participation of host immune cells

  2010cites this paper
• Homing in on acute graft vs. host disease: tissue-specific T regulatory and Th17 cells.

  2010cites this paper
• Проявление иммунокорригирующего эффекта криоконсервированных клеток фетальной печени разных сроков гестации в условиях развития экспериментальной модели реакции «Трансплантат против хозяина»*

  2010cites this paper
• Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome

  2010influential citation
• Relapse after allogeneic stem cell transplantation

  2010cites this paper
• Deep venous thrombosis or pulmonary embolism and factor V Leiden: enigma or paradox

  2010cites this paper
• Graft-versus-host disease.

  2010cites this paper
• New perspectives on the biology of acute GVHD

  2010cites this paper
• Dermatologic manifestations of hematopoietic stem cell transplantation: understanding and management

  2009cites this paper
• Anti-CD3 preconditioning separates GVL from GVHD via modulating host dendritic cell and donor T-cell migration in recipients conditioned with TBI.

  2009cites this paper
• POLYMORPHISMES NON-HLA ET EVOLUTION POST-ALLOGREFFE DE CELLULES SOUCHES HEMATOPOÏETIQUES

  2009cites this paper
• Glycosyltransferase‐programmed stereosubstitution (GPS) to create HCELL: engineering a roadmap for cell migration

  2009cites this paper
• Mouse models of graft-versus-host disease

  2009cites this paper
• Cutaneous Chronic Graft-Versus-Host Disease Does Not Have the Abnormal Endothelial Phenotype or Vascular Rarefaction Characteristic of Systemic Sclerosis

  2009cites this paper
• Isolated Extramedullary Relapse of Acute Leukemia after Allogeneic Stem Cell Transplantation: Different Kinetics and Better Prognosis than Systemic Relapse.

  2009cites this paper
• Pharmacologic Prevention of Acute Graft‐Versus‐Host Disease

  2009cites this paper
• Expression of CD62L on Donor CD4+ T Cells in Allografts: Correlation with Graft-Versus-Host Disease after Unmanipulated Allogeneic Blood and Marrow Transplantation

  2009cites this paper
• Biology and management of acute graft-versus-host disease.

  2009cites this paper
• In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity.

  2008cites this paper
• Organ-derived dendritic cells have differential effects on alloreactive T cells.

  2008cites this paper
• Inflammatory cytokines and dendritic cells in acute graft-versus-host disease after allogeneic stem cell transplantation.

  2008cites this paper
• Role of dendritic cells and chemokines in acute graft-versus-host disease.

  2008cites this paper
• Pathophysiology of Acute Graft-vs-Host Disease: Recent Advances

  2008cites this paper
• Mesenchymal Stem Cells Alter Migratory Property of T and Dendritic Cells to Delay the Development of Murine Lethal Acute Graft‐Versus‐Host Disease

  2008cites this paper
• Dendritic cells and acute graft-versus-host disease after allogeneic stem cell transplantation

  2007cites this paper
• The Pathophysiology of Graft‐Versus‐Host Disease

  2007cites this paper
• Pathophysiology of acute graft-versus-host disease: recent advances.

  2007cites this paper
• SUBSPECIALTY IN TRANSLATIONAL MEDICINE of acute graft-versus-host disease: recent advances

  2007cites this paper
• Donor CD8+ T Cells Mediate Graft-versus-Leukemia Activity without Clinical Signs of Graft-versus-Host Disease in Recipients Conditioned with Anti-CD3 Monoclonal Antibody1

  2007cites this paper
• Monoclonal Antibody Recipients Conditioned with Anti-CD3 Clinical Signs of Graft-versus-Host Disease in Graft-versus-Leukemia Activity without T Cells Mediate + Donor CD8

  2006cites this paper